Mechanistic insights into KRAS G12D inhibitor binding revealed by molecular dynamics simulations of multiple crystal structures
Physical Chemistry Chemical Physics · 2026
DOI: 10.1039/d5cp03384e ↗At a glance
Journal article in Physical Chemistry Chemical Physics, 2026. Written by Donghwan Kim and 2 co-authors. Institution: Atomatrix, 851, Daewangpangyo-ro 815, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea. sblee@atomatrix.co.kr. Major MEDLINE topics: Molecular Dynamics Simulation, Proto-Oncogene Proteins p21(ras). 53 references.
Abstract (original language)
The discovery of selective and potent KRAS G12D inhibitors remains a critical priority in oncology drug development.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Atomatrix, 851, Daewangpangyo-ro 815, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea. sblee@atomatrix.co.kr.
Cite
APA
Kim, D., Lee, E., & Lee, S. (2026). Mechanistic insights into KRAS G12D inhibitor binding revealed by molecular dynamics simulations of multiple crystal structures. Physical Chemistry Chemical Physics. https://doi.org/10.1039/d5cp03384e
Vancouver
Kim D, Lee E, Lee S. Mechanistic insights into KRAS G12D inhibitor binding revealed by molecular dynamics simulations of multiple crystal structures. Physical Chemistry Chemical Physics. 2026. doi:10.1039/d5cp03384e
BibTeX
@article{Kim2026,
author = {Kim, Donghwan and Lee, Eunho and Lee, Sangbae},
title = {Mechanistic insights into KRAS G12D inhibitor binding revealed by molecular dynamics simulations of multiple crystal structures},
journal = {Physical Chemistry Chemical Physics},
year = {2026},
doi = {10.1039/d5cp03384e}
}
EUVIMED